Skip to main content
Skip to navigation

Rolls-Royce Faces SFO Bribery Probe

By Jaclyn Jaeger2013-12-23T11:45:00

THIS IS MEMBERS-ONLY CONTENT

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

Related articles

Blog
SFO faces criticism for closing Rolls-Royce, GSK cases

2019-02-22T11:30:00Z By Jaclyn Jaeger

The U.K. Serious Fraud Office closed two long-running bribery and corruption cases against Rolls-Royce and GlaxoSmithKline—a decision that casts further doubt around the effectiveness of the SFO’s investigatory powers and makes companies question the purpose of entering a deferred prosecution agreement at all.
Article
Compliance, Rolls-Royce, and DPAs—what went wrong?

2017-04-11T13:30:00Z By Raj Chada

If the Rolls-Royce deferred prosecution agreement is any indicator, the Serious Fraud Office plans to make heavier use of DPAs going forward, especially for companies with paper compliance programs.
News Brief
DOJ targets $14.6B in health care fraud with focus on transnational crime

2025-07-02T18:31:00Z By Aaron Nicodemus

Emerging enforcement priorities of the U.S. Department of Justice’s health care fraud division align with the Trump administration’s emphasis on prosecuting transnational criminal organizations and ending opioid trafficking.